New registry to monitor brain ultrasound for Parkinson's tremors

NCT ID NCT05539196

Recruiting now Disease control Sponsor: InSightec Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks people with advanced Parkinson's disease who receive a treatment called Exablate, which uses focused ultrasound to target a small area in the brain. The goal is to see how well it reduces medication-resistant motor problems like shaking and stiffness. Researchers will follow 60 participants for up to 5 years to measure improvements and any side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MOVEMENT DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

movement disorder Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MOVEMENT DISORDERS NEUROLOGY PARKINSONS DISEASE

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Ohnishi Neurological Center
RECRUITING

Akashi, Hyōgo, 674-0064, Japan

Contact Email: •••••@•••••
University of Maryland, Baltimore
RECRUITING

Baltimore, Maryland, 21201, United States
University of Pennsylvania
RECRUITING

Philadelphia, Pennsylvania, 19106, United States
University of Texas Southwestern Medical Center
RECRUITING

Dallas, Texas, 75390, United States
Weill Cornell Medicine
RECRUITING

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.